Chemotaxis receptors and signaling

Advances in Protein Chemistry

Volumn 68, Issue , 2004, Pages 393-444

  Miller, Aaron F ^a   Falke, Joseph J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; G PROTEIN COUPLED RECEPTOR; RHODOPSIN;

CELL ACTIVITY; CHEMOTAXIS; IMMUNE SYSTEM; LEUKOCYTE MIGRATION; LIGAND BINDING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DIMERIZATION; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CHEMOTAXIS; DIMERIZATION; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, G-PROTEIN-COUPLED; RHODOPSIN; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 16544390232     PISSN: 00653233     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3233(04)68011-9     Document Type: Article

References (198)

1. Ahuja, S. K., Lee, J. C., and Murphy, P. M. (1996). CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. J. Biol. Chem. 271, 225-232.
2. Ai, L. S., and Liao, F. (2002). Mutating the four extracellular cysteines in the chemokine receptor CCR6 reveals their differing roles in receptor trafficking, ligand binding, and signaling. Biochem. 41, 8332-8341.
3. Altenbach, C., Yang, K., Farrens, D. L., Farahbakhsh, Z. T., Khorana, H. G., and Hubbell, W. L. (1996). Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study. Biochem. 35, 12470-12478.
4. Amatruda, T. T., 3rd, Gerard, N. P., Gerard, C., and Simon, M. I. (1993). Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268, 10139-10144.
5. Aramori, I., Ferguson, S. S., Bieniasz, P. D., Zhang, J., Cullen, B., and Cullen, M. G. (1997). Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J. 16, 4606-4616.
6. Archer, E., Maigret, B., Escrieut, C., Pradayrol, L., and Fourmy, D. (2003). Rhodopsin crystal: New template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol. Sci. 24, 36-40.
7. Arias, D. A., Navenot, J. M., Zhang, W. B., Broach, J., and Peiper, S. C. (2003). Constitutive Activation of CCR5 and CCR2 Induced by Conformational Changes in the Conserved TXP Motif in Transmembrane Helix 2. J. Biol. Chem. 278, 36513-36521.
8. Arnis, S., Fahmy, K., Hofmann, K. P., and Sakmar, T. P. (1994). A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269, 23879-23881.
9. Atchison, R. E., Gosling, J., Monteclaro, F. S., Franci, C., Digilio, L., Charo, I. F., and Goldsmith, M. A. (1996). Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines. Science 274, 1924-1926.
10. Attwood, T. K. (2001). A compendium of specific motifs for diagnosing GPCR subtypes. Trends Pharmacol. Sci. 22, 162-165.
11. Auger, G. A., Pease, J. E., Shen, X., Xanthou, G., and Barker, M. D. (2002). Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression. Eur. J. Immunol. 32, 1052-1058.
12. Baggiolini, M. (1998). Chemokines and leukocyte traffic. Nature 392, 565-568.
13. Baggiolini, M., Dewald, B., and Moser, B. (1997). Human chemokines: An update. Annu. Rev. Immunol. 15, 675-705.
14. Baldwin, E. T., Weber, I. T., St Charles, R., Xuan, J. C., Appella, E., Yamada, M., Matsushima, K., Edwards, B. F., Clore, G. M., and Gronenborn, A. M. (1991). Crystal structure of interleukin 8: Symbiosis of NMR and crystallography. Proc. Natl. Acad. Sci. USA 88, 502-506.
15. Ballesteros, J. A., Jensen, A. D., Liapakis, G., Rasmussen, S. G., Shi, L., Gether, U., and Javitch, J. A. (2001). Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171-29177.
16. Ballesteros, J. A., and Weinstein, H. (1995). Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366-428.
17. Barak, L. S., Menard, L., Ferguson, S. S., Colapietro, A. M., and Caron, M. G. (1995). The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. Biochem. 34, 15407-15414.
18. Barak, L. S., Tiberi, M., Freedman, N. J., Kwatra, M. M., Lefkowitz, R. J., and Caron, M. G. (1994). A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. J. Biol. Chem. 269, 2790-2795.
19. Baranski, T. J., Herzmark, P., Lichtarge, O., Gerber, B. O., Trueheart, J., Meng, E. C., Iiri, T., Sheikh, S. P., and Bourne, H. R. (1999). C5a receptor activation. Genetic identification of critical residues in four transmembrane helices. J. Biol. Chem. 274, 15757-15765.
20. Barr, A. J., Ali, H., Haribabu, B., Snyderman, R., and Smrcka, A. V. (2000). Identification of a region at the N-terminus of phospholipase C-beta 3 that interacts with G protein beta gamma subunits. Biochem. 39, 1800-1806.
21. Becker, O. M., Shacham, S., Marantz, Y., and Noiman, S. (2003). Modeling the 3D structure of GPCRs: Advances and application to drug discovery. Curr. Opin. Drug Discov. Devel. 6, 353-361.
22. Benkirane, M., Jin, D. Y., Chun, R. F., Koup, R. A., and Jeang, K. T. (1997). Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272, 30603-30606.
23. Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C., De Leener, A., Vassart, G., Doms, R. W., Proudfoot, A., and Parmentier, M. (2003). The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 278, 5179-5187.
24. Blanpain, C., Doranz, B. J., Vakili, J., Rucker, J., Govaerts, C., Baik, S. S., Lorthioir, O., Migeotte, I., Libert, F., Baleux, F., Vassart, G., Doms, R. W., and Parmentier, M. (1999a). Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HFV-1 Env protein. J. Biol. Chem. 274, 34719-34727.
25. Blanpain, C., Migeotte, I., Lee, B., Vakili, J., Doranz, B. J., Govaerts, C., Vassart, G., Doms, R. W., and Parmentier, M. (1999b). CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94, 18900-18905.
26. Blanpain, C., Wittamer, V., Vanderwinden, J. M., Boom, A., Renneboog, B., Lee, B., Le Poul, E., El Asmar, L., Govaerts, C., Vassart, G., Doms, R. W., and Parmentier, M. (2001). Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J. Biol. Chem. 276, 23795-23804.
27. Bokoch, G. M. (1995). Chemoattractant signaling and leukocyte activation. Blood 86, 1649-1660.
28. Bokoch, G. M., Bickford, K., and Bohl, B. P. (1988). Subcellular localization and quantitation of the major neutrophil pertussis toxin substrate, Gn. J. Cell Biol. 106, 1927-1936.
29. Bokoch, G. M., and Gilman, A. G. (1984). Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin. Cell 39, 301-308.
30. Boulay, F., Mery, L., Tardif, M., Brouchon, L., and Vignais, P. (1991). Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochem. 30, 2993-2999.
31. Brady, A. E., and Limbird, L. E. (2002). G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction. Cell Signal. 14, 297-309.
32. Cai, K., Klein-Seetharaman, J., Hwa, J., Hubbell, W. L., and Khorana, H. G. (1999). Structure and function in rhodopsin: Effects of disulfide cross-links in the cytoplasmic face of rhodopsin on transducin activation and phosphorylation by rhodopsin kinase. Biochem. 38, 12893-12898.
33. Campanella, J. J., Bitincka, L., and Smalley, J. (2003). MatGAT: An application that generates similarity/identity matrices using protein or DNA sequences. BMC Bioinformatics 4, 29.
34. Catusse, J., Liotard, A., Loillier, B., Pruneau, D., and Paquet, J. L. (2003). Characterization of the molecular interactions of intcrleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochem. Pharmacol. 65, 813-821.
35. Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J., and Coughlin, S. R. (1994). Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91, 2752-2756.
36. Chung, C. Y., and Firtel, R. A. (2002). Signaling pathways at the leading edge of chemotaxing cells. J. Muscle Res. Cell Motil. 23, 773-779.
37. Cohen, G. B., Yang, T., Robinson, P. R., and Oprian, D. D. (1993). Constitutive activation of opsin: Influence of charge at position 134 and size at position 296. Biochem. 32, 6111-6115.
38. DeMartino, J. A., Konteatis, Z. D., Siciliano, S. J., Van Riper, G., Underwood, D. J., Fischer, P. A., and Springer, M. S. (1995). Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J. Biol Chem. 270, 15966-15969.
39. DeMartino, J. A., Van Riper, G., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., and Springer, M. S. (1994). The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269, 14446-14450.
40. Devreotes, P., and Janetopoulos, C. (2003). Eukaryotic chemotaxis: Distinctions between directional sensing and polarization. J. Biol. Chem. 278, 20445-20448.
41. Dohlman, H. G., Caron, M. G., DeBlasi, A., Frielle, T., and Lefkowitz, R. J. (1990). Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. Biochem. 29, 2335-2342.
42. Dragic, T., Trkola, A., Thompson, D. A., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., and Moore, J. P. (2000). A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 97, 5639-5644.
43. Dryer, L., and Berghard, A. (1999). Odorant receptors: A plethora of G-protein-coupled receptors. Trends Pharmacol. Sci. 20, 413-417.
44. Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., and Khorana, H. G. (1996). Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770.
45. Feltner, D. E., Smith, R. H., and Marasco, W. A. (1986). Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors. J. Immunol. 137, 1961-1970.
46. Filipek, S., Stenkamp, R. E., Teller, D. C., and Palczewski, K. (2003). G protein-coupled receptor rhodopsin: A prospectus. Annu. Rev. Physiol. 65, 851-879.
47. Firtel, R. A., and Chung, C. Y. (2000). The molecular genetics of chemotaxis: Sensing and responding to chemoattractant gradients. Bioessays 22, 603-615.
48. Floyd, D. H., Geva, A., Bruinsma, S. P., Overton, M. C., Blumer, K. J., and Baranski, T. J. (2003). C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. J. Biol. Chem. 278, 35354-35361.
49. Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A., and Palczewski, K. (2003). Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature 421, 127-128.
50. Freer, R. J., Day, A. R., Muthukumaraswamy, N., Pinon, D., Wu, A., Showell, H. J., and Becker, E. L. (1982). Formyl peptide chemoattractants: A model of the receptor on rabbit neutrophils. Biochem. 21, 257-263.
51. Freer, R. J., Day, A. R., Radding, J. A., Schiffmann, E., Aswanikumar, S., Showell, H. J., and Becker, E. L. (1980). Further studies on the structural requirements for synthetic peptide chemoattractants. Biochem. 19, 2404-2410.
52. Fritze, O., Filipek, S., Kuksa, V., Palczewski, K., Hofmann, K. P., and Ernst, O. P. (2003). Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc. Natl. Acad. Sci. USA 100, 2290-2295.
53. Funamoto, S., Meili, R., Lee, S., Parry, L., and Firtel, R. A. (2002). Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109, 611-623.
54. Gallin, J. I., and Snyderman, R. (1999). Inflammation: Basic principles and clinical correlates. Lippincott Williams & Wilkins, Philadelphia, PA.
55. Garcia Rodriguez, C., Cundell, D. R., Tuomanen, E. I., Kolakowski, L. F., Jr., Gërard, C., and Gerard, N. P. (1995). The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking. J. Biol. Chem. 270, 25178-25184.
56. Gayle, R. B., 3rd, Sleath, P. R., Srinivason, S., Birks, C. W., Weerawarna, K. S., Cerretti, D. P., Kozlosky, C. J., Nelson, N., Vanden Bos, T., and Beckmann, M. P. (1993). Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J. Biol. Chem. 268, 7283-7289.
57. Gerard, C., and Gerard, N. P. (1994). C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775-808.
58. Gerard, N. P., and Gerard, C. (1991). The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
59. Gether, U. (2000). Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90-113.
60. Gether, U., Lin, S., Ghanouni, P., Ballesteros, J. A., Weinstein, H., and Kobilka, B. K. (1997). Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J. 16, 6737-6747.
61. Geva, A., Lassere, T. B., Lichtarge, O., Pollitt, S. K., and Baranski, T. J. (2000). Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function. J. Biol. Chem. 275, 35393-35401.
62. Ghanouni, P., Steenhuis, J. J., Farrens, D. L., and Kobilka, B. K. (2001). Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc. Natl. Acad. Sci. USA 98, 5997-6002.
63. Goldman, D. W., Chang, F. H., Gifford, L. A., Goetzl, E. J., and Bourne, H. R. (1985). Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J. Exp. Med. 162, 145-156.
64. Gosling, J., Monteclaro, F. S., Atchison, R. E., Arai, H., Tsou, C. L., Goldsmith, M. A., and Charo, I. F. (1997). Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061-5066.
65. Govaerts, C., Blanpain, C., Deupi, X., Ballet, S., Ballesteros, J. A., Wodak, S. J., Vassart, G., Pardo, L., and Parmentier, M. (2001). The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation. J. Biol. Chem. 276, 13217-13225.
66. Govaerts, C., Bondue, A., Springael, J. Y., Olivella, M., Deupi, X., Le Poul, E., Wodak, S. J., Parmentier, M., Pardo, L., and Blanpain, C. (2003). Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J. Biol. Chem. 278, 1892-1903.
67. Graul, R. C., and Sadee, W. (2001). Evolutionary relationships among G protein-coupled receptors using a clustered database approach. AAPS PharmSci. 3, E12.
68. Greasley, P. J., Fanelli, F., Scheer, A., Abuin, L., Nenniger-Tosato, M., DeBenedetti, P. G., and Cotecchia, S. (2001). Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J. Biol. Chem. 276, 46485-46494.
69. Gripentrog, J. M., Jesaitis, A. J., and Miettinen, H. M. (2000). A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis. Biochem. J. 352(Pt 2), 399-407.
70. Gripentrog, J. M., Kantele, K. P., Jesaitis, A. J., and Miettinen, H. M. (2003). Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor. J. Immunol. 171, 3187-3193.
71. Han, K. H., Green, S. R., Tangirala, R. K., Tanaka, S., and Quehenberger, O. (1999). Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling. J. Biol. Chem. 274, 32055-32062.
72. He, R., Browning, D. D., and Ye, R. D. (2001). Differential roles of the NPXXY motif in formyl peptide receptor signaling. J. Immunol. 166, 4099-4105.
73. Hebert, T. E., Moffett, S., Morello, J. P., Loisel, T. P., Bichet, D. G., Barret, C., and Bouvier, M. (1996). A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392.
74. Henderson, R., Baldwin, J. M., Ceska, T. A., Zemlin, F., Beckmann, E., and Downing, K. H. (1990). Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy. J. Mol. Biol. 213, 899-929.
75. Hodges, P. E., Carrico, P. M., Hogan, J. D., O'Neill, K. E., Owen, J. J., Mangan, M., Davis, B. P., Brooks, J. E., and Garrels, J. I. (2002). Annotating the human proteome: The Human Proteome Survey Database (HumanPSD) and an in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acids Res. 30, 137-141.
76. Hogger, P., Shockley, M. S., Lameh, J., and Sadee, W. (1995). Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors. J. Biol. Chem. 270, 7405-7410.
77. Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C., and Wood, W. I. (1991). Structure and functional expression of a human interleukin-8 receptor. Science 253, 1278-1280.
78. Horn, F., Bettler, E., Oliveira, L., Campagne, F., Cohen, F. E., and Vriend, G. (2003). GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res. 31, 294-297.
79. Huang, P., Visiers, I., Weinstein, H., and Liu-Chen, L. Y. (2002). The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: Introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates die mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant. Biochem. 41, 11972-11980.
80. Hubbell, W. L., Altenbach, C., Hubbell, C. M., and Khorana, H. G. (2003). Rhodopsin structure, dynamics, and activation: A perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 63, 243-290.
81. Hubbell, W. L., Cafiso, D. S., and Altenbach, C. (2000). Identifying conformational changes with site-directed spin labeling. Nat. Struct. Biol. 7, 735-739.
82. Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Padgaonkar, V. A., Younkin, E. M., Guo, R. F., Weber, C. H., Zuiderweg, E. R., Zetoune, F. S., and Ward, P. A. (2003). Structure-function relationships of human C5a and C5aR. J. Immunol. 170, 6115-6124.
83. Hunte, C., and Michel, H. (2002). Crystallisation of membrane proteins mediated by antibody fragments. Curr. Opin. Struct. Biol. 12, 503-508.
84. Iijima, M., and Devreotes, P. (2002). Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 109, 599-610.
85. Issafras, H., Angers, S., Bulenger, S., Blanpain, C., Parmentier, M., Labbejullie, C., Bouvier, M., and Marullo, S. (2002). Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J. Biol. Chem. 277, 34666-34673.
86. Jones, B. E., Miettinen, H. M., Jesaitis, A. J., and Mills, J. S. (2003). Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis. J. Periodontol. 74, 475-484.
87. Katancik, J. A., Sharma, A., and de Nardin, E. (2000). Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 12, 1480-1488.
88. Kim, J. M., Altenbach, C., Thurmond, R. L., Khorana, H. G., and Hubbell, W. L. (1997). Structure and function in rhodopsin: Rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state. Proc. Natl. Acad. Sci. USA 94, 14273-14278.
89. Klco, J. M., Lassere, T. B., and Baranski, T. J. (2003). C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J. Biol. Chem. 278, 35345-35353.
90. Knall, C., Worthen, G. S., and Johnson, G. L. (1997). Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 94, 3052-3057.
91. Kolakowski, L. F., Jr., Lu, B., Gerard, C., and Gerard, N. P. (1995). Probing the "message:address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments. J. Biol. Chem. 270, 18077-18082.
92. Konvicka, K., Guarnieri, F., Ballesteros, J. A., and Weinstein, H. (1998). A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif. Biophys. J. 75, 601-611.
93. Koo, C., Lefkowitz, R. J., and Snyderman, R. (1983). Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes. J. Clin. Invest. 72, 748-753.
94. Kotani, M., Mollereau, C., Detheux, M., Le Foul, E., Brezillon, S., Vakili, J., Mazarguil, H., Vassart, G., Zajac, J. M., and Parmentier, M. (2001). Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133, 138-144.
95. Kraft, K., OIbrich, H., Majoul, I., Mack, M., Proudfoot, A., and Oppermann, M. (2001). Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. J. Biol. Chem. 276, 34408-34418.
96. Krebs, A., Edwards, P. C., Villa, C., Li, J., and Schertler, G. F. (2003). The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J. Biol. Chem. 278, 50217-50225.
97. Krebs, A., Villa, C., Edwards, P. C., and Schertler, G. F. (1998). Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin. J. Mol. Biol. 282, 991-1003.
98. Krupnick, J. G., and Benovic, J. L. (1998). The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38, 289-319.
99. LaRosa, G. J., Thomas, K. M., Kaufmann, M. E., Mark, R., White, M., Taylor, L., Gray, G., Witt, D., and Navarro, J. (1992). Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J. Biol. Chem. 267, 25402-25406.
100. Laurence, J. S., Blanpain, C., Burgner, J. W., Parmentier, M., and LiWang, P. J. (2000). CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochem. 39, 3401-3409.
101. Le, Y., Murphy, P. M., and Wang, J. M. (2002). Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548.
102. Lee, S. P., O'Dowd, B. F., Ng, G. Y., Varghese, G., Akil, H., Mansour, A., Nguyen, T., and George, S. R. (2000). Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol. Pharmacol. 58, 120-128.
103. Lee, S. P., O'Dowd, B. F., Rajaram, R. D., Nguyen, T., and George, S. R. (2003). D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochem. 42, 11023-11031.
104. Leong, S. R., Kabakoff, R. C., and Hebert, C. A. (1994). Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J. Biol. Chem. 269, 19343-19348.
105. Li, Z., Jiang, H., Xie, W., Zhang, Z., Smrcka, A. V., and Wu, D. (2000). Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287, 1046-1049.
106. Liang, Y., Fotiadis, D., Filipek, S., Saperstein, D. A., Palczewski, K., and Engel, A. (2003). Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278, 21655-21662.
107. Lim, C. J., Spiegelman, G. B., and Weeks, G. (2001). RasC is required for optimal activation of adenylyl cyclase and Akt/PKB during aggregation. EMBO J. 20, 4490-4499.
108. Littman, D. R. (1998). Chemokine receptors: Keys to AIDS pathogenesis? Cell 93, 677-680.
109. Locati, M., and Murphy, P. M. (1999). Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50, 425-440.
110. Lopez-Ilasaca, M., Crespo, P., Pellici, P. G., Gutkind, J. S., and Wetzker, R. (1997). Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275, 394-397.
111. Lowman, H. B., Fairbrother, W. J., Slagle, P. H., Kabakoff, R., Liu, J., Shire, S., and Hebert, C. A. (1997). Monomeric variants of IL-8: Effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci. 6, 598-608.
112. Luttrell, L. M. (2002). Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can. J. Physiol. Phannacol. 80, 375-382.
113. Ma, Y. C., Huang, J., Ali, S., Lowry, W., and Huang, X. Y. (2000). Src tyrosine kinase is a novel direct effector of G proteins. Cell 102, 635-646.
114. Mackay, C. R. (2001). Chemokines: Immunology's high impact factors. Nat. Immunol. 2, 95-101.
115. Mackay, D. J., and Hall, A. (1998). Rho GTPases. J. Biol. Chem. 273, 20685-20688.
116. Maghazachi, A. A. (1999). Intracellular signalling pathways induced by chemokines in natural killer cells. Cell. Signal. 11, 385-390.
117. Marasco, W. A., Phan, S. H., Knitzsch, H., Showell, H. J., Feltner, D. E., Nairn, R., Becker, E. L., and Ward, P. A. (1984). Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259, 5430-5439.
118. Mellado, M., Rodriguez-Frade, J. M., Aragay, A., del Real, G., Martin, A. M., Vila-Coro, A. J., Serrano, A., Mayor, F., Jr., and Martinez, A. C. (1998). The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 161, 805-813.
119. Mellado, M., Rodriguez-Frade, J. M., Vila-Coro, A. J., Fernandez, S., Martin de Ana, A., Jones, D. R., Toran, J. L., and Martinez, A. C. (2001). Chemokine receptor homo- or heterodimerization activates distinct signaling patlnvays. EMBO J. 20, 2497-2507.
120. Meng, E. C., and Bourne, H. R. (2001). Receptor activation: What does the rhodopsin structure tell us? Trends Pharmacol. Sci. 22, 587-593.
121. Merlot, S., and Firtel, R. A. (2003). Leading the way: Directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J. Cell. Sci. 116, 3471-3478.
122. Miettinen, H. M., Gripentrog, J. M., Mason, M. M., andjesaitis, A. J. (1999). Identification of putative sites of interaction between the human formyl peptide receptor and G protein. J. Biol. Chem. 274, 27934-27942.
123. Miettinen, H. M., Mills, J. S., Gripentrog, J. M., Dratz, E. A., Granger, B. L., and Jesaitis, A. J. (1997). The ligand binding site of the formyl peptide receptor maps in the transmembrane region. J. Immunol. 159, 4045-4054.
124. Mills, J. S., Miettinen, H. M., Barnidge, D., Vlases, M. J., Wimer-Mackin, S., Dratz, E. A., Sunner, J., andjesaitis, A. J. (1998). Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. J. Biol. Chem. 273, 10428-10435.
125. Mills, J. S., Miettinen, H. M., Cummings, D., and Jesaitis, A. J. (2000). Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu. J. Biol. Chem. 275, 39012-39017.
126. Monteclaro, F. S., and Charo, I. F. (1997). The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand. J. Biol. Chem. 272, 23186-23190.
127. Murphy, P. M. (1994). The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633.
128. Murphy, P. M. (2002). International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54, 227-229.
129. Murphy, P. M., and Tiffany, H. L. (1991). Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253, 1280-1283.
130. Murphy, P. M., Tiffany, H. L., McDermott, D., and Ahuja, S. K. (1993). Sequence and organization of the human N-formyl peptide receptor-encoding gene. Gene 133, 285-290.
131. Navenot, J. M., Wang, Z. X., Trent, J. O., Murray, J. L., Hu, Q. X., DeLeeuw, L., Moore, P. S., Chang, Y., and Peiper, S. C. (2001). Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: Differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II binding. J. Mol. Biol. 313, 1181-1193.
132. Neptune, E. R., and Bourne, H. R. (1997). Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc. Natl. Acad. Sci. USA 94, 14489-14494.
133. Nick, J. A., Avdi, N. J., Young, S. K., Knall, C., Gerwins, P., Johnson, G. L., and Worthen, G. S. (1997). Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99, 975-986.
134. Ogilvie, P., Bardi, G., Clark-Lewis, I., Baggiolini, M., and Uguccioni, M. (2001). Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97, 1920-1924.
135. Pacold, M. E., Suire, S., Perisic, O., Lara-Gonzalez, S., Davis, C. T., Walker, E. H., Hawkins, P. T., Stephens, L., Eccleston, J. F., and Williams, R. L. (2000). Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103, 931-943.
136. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. (2000). Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745.
137. Parent, C. A., and Devreotes, P. N. (1999). A cell's sense of direction. Science 284, 765-770.
138. Partida-Sanchez, S., Cockayne, D. A., Monard, S., Jacobson, E. L., Oppenheimer, N., Garvy, B., Kusser, K., Goodrich, S., Howard, M., Harmsen, A., Randall, T. D., and Lund, F. E. (2001). Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat. Med. 7, 1209-1216.
139. Prioleau, C., Visiers, I., Ebersole, B. J., Weinstein, H., and Sealfon, S. C. (2002). Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revenant mutations. J. Biol. Chem. 277, 36577-36584.
140. Prossnitz, E. R. (1997). Desensitization of N-formylpeptide receptor-mediated activation is dependent upon receptor phosphorylation. J. Biol. Chem. 272, 15213-15219.
141. Prossnitz, E. R., Gilbert, T. L., Chiang, S., Campbell, J. J., Qin, S., Newman, W., Sklar, L. A., and Ye, R. D. (1999). Multiple activation steps of the N-formyl peptide receptor. Biochem. 38, 2240-2247.
142. Prossnitz, E. R., Schreiber, R. E., Bokoch, G. M., and Ye, R. D. (1995). Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate. J. Biol. Chem. 270, 10686-10694.
143. Prossnitz, E. R., and Ye, R. D. (1997). The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74, 73-102.
144. Qanbar, R., and Bouvier, M. (2003). Role of palmitoylation/ depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 1-33.
145. Rao, V. R., Cohen, G. B., and Oprian, D. D. (1994). Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367, 639-642.
146. Rasmussen, S. G., Jensen, A. D., Liapakis, G., Ghanouni, P., Javitch, J. A., and Gether, U. (1999). Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: Constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol. Pharmacol. 56, 175-184.
147. Rediske, J. J., Quintavalla, J. C., Haston, W. O., Morrissey, M. M., and Seligman, B. (1992). Platelet activating factor stimulates intracellular calcium transients in human neutrophils: Involvement of endogenous 5-lipoxygenase products. J. Leukoc. Biol. 51, 484-489.
148. Rodriguez-Frade, J. M., Vila-Coro, A. J., de Ana, A. M., Albar, J. P., Martinez, A. C., and Mellado, M. (1999). The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. USA 96, 3628-3633.
149. Sakmar, T. P. (2002). Structure of rhodopsin and the superfamily of seven-helical receptors: The same and not the same. Curr. Opin. Cell Biol. 14, 189-195.
150. Sanders, S. K., Crean, S. M., Boxer, P. A., Kellner, D., LaRosa, G. J., and Hunt, S. W., 3rd (2000). Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J. Immunol. 165, 4877-4883.
151. Sankaran, B., Osterhout, J., Wu, D., and Smrcka, A. V. (1998). Identification of a structural element in phospholipase C beta2 that interacts with G protein beta-gamma subunits. J. Biol. Chem. 273, 7148-7154.
152. Sansom, M. S., and Weinstein, H. (2000). Hinges, swivels and switches: The role of prolines in signalling via transmembrane alpha-helices. Trends Pharmacol. Sci. 21, 445-451.
153. Scheer, A., Costa, T., Fanelli, F., De Benedetti, P. G., Mhaouty-Kodja, S., Abuin, L., Nenniger-Tosato, M., and Cotecchia, S. (2000). Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: Effects on receptor isomerization and activation. Mol. Pharmacol. 57, 219-231.
154. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., and Cotecchia, S. (1996). Constitutively active mutants of the alpha 1B-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO J. 15, 3566-3578.
155. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., and Cotecchia, S. (1997). The activation process of the alpha1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. USA 94, 808-813.
156. Seifert, R., and Wenzel-Seifert, K. (2001a). Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis. J. Biol. Chem. 276, 42043-42049.
157. Seifert, R., and Wenzel-Seifert, K (2001b). Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state. Receptors Channels 7, 357-369.
158. Seifert, R., and Wenzel-Seifert, K. (2003). The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors. Life Sci. 73, 2263-2280.
159. Shapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K., and Roth, B. L. (2002). Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 277, 11441-11449.
160. Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., andjavitch, J. A. (2002). Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277, 40989-40996.
161. Siciliano, S. J., Rollins, T. E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H., and Springer, M. S. (1994). Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 91, 1214-1218.
162. Sieving, P. A., Fowler, M. L., Bush, R. A., Machida, S., Calvert, P. D., Green, D. G., Makino, C. L., and McHenry, C. L. (2001). Constitutive "light" adaptation in rods from G90D rhodopsin: A mechanism for human congenital nightblindness without rod cell loss. J. Neurosci. 21, 5449-5460.
163. Skelton, N. J., Quan, C., Reilly, D., and Lowman, H. (1999). Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure Fold Des. 7, 157-168.
164. Smith, C. D., Cox, C. C., and Snyderman, R. (1986). Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. Science 232, 97-100.
165. Spisani, S., Turchetti, M., Varani, K., Falzarano, S., and Cavicchioni, G. (2003). Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket. Eur. J. Pharmacol. 469, 13-19.
166. Sprang, S. R. (1997). G protein mechanisms: Insights from structural analysis. Annu. Rev. Biochem. 66, 639-678.
167. Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., and Hawkins, P. T. (1997). The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89, 105-114.
168. Stoyanov, B., Volinia, S., Hanck, T., Rubio, I., Loubtchenkov, M., Malek, D., Stoyanova, S., Vanhaesebroeck, B., Dhand, R., Nurnberg, B. et al. (1995). Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269, 690-693.
169. Suetomi, K., Rojo, D., and Navarro, J. (2002). Identification of a signal transduction switch in the chemokine receptor CXCR1. J. Biol. Chem. 277, 31563-31566.
170. Takeda, S., Kadowaki, S., Haga, T., Takaesu, H., and Mitaku, S. (2002). Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett. 520, 97-101.
171. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617.
172. Thelen, M. (2001). Dancing to the tune of chemokines. Nat. Immunol. 2, 129-134.
173. Thordsen, I., Polzer, S., and Schreiber, M. (2002). Infection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1. BMC Infect. Dis. 2, 31.
174. Trettel, F., Di Bartolomeo, S., Lauro, C., Catalano, M., Ciotti, M. T., and Limatola, C. (2003). Ligand-independent CXCR2 dimerization. J. Biol. Chem. 278, 40980-10988.
175. Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., and Moore, J. P. (1996). CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187.
176. Unger, V. M., Hargrave, P. A., Baldwin, J. M., and Schertler, G. F. (1997). Arrangement of rhodopsin transmembrane alpha-helices. Nature 389, 203-206.
177. Vaidehi, N., Floriano, W. B., Trabanino, R., Hall, S. E., Freddolino, P., Choi, E. J., Zamanakos, G., and Goddard, W. A., 3rd (2002). Prediction of structure and function of G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 99, 12622-12627.
178. Verghese, M. W., Smith, C. D., and Snyderman, R. (1986). Role of guanine nucleotide regulatory protein in polyphosphoinositide degradation and activation of phagocytic leukocytes by chemoattractants. J. Cell Biochem. 32, 59-69.
179. Vila-Coro, A. J., Mellado, M., Martin de Ana, A., Lucas, P., del Real, G., Martinez, A. C., and Rodriguez-Frade, J. M. (2000). HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. USA 97, 3388-3393.
180. Vila-Coro, A. J., Rodriguez-Frade, J. M., Martin De Ana, A., Moreno-Ortiz, M. C., Martinez, A. C., and Mellado, M. (1999). The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13, 1699-1710.
181. Visiers, I., Ballesteros, J. A., and Weinstein, H. (2002). Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol. 343, 329-371.
182. Wang, F., Herzmark, P., Weiner, O. D., Srinivasan, S., Servant, G., and Bourne, H. R. (2002). Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat. Cell Biol. 4, 513-518.
183. Weiner, O. D., Neilsen, P. O., Prestwich, G. D., Kirschner, M. W., Cantley, L. C., and Bourne, H. R. (2002). A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat. Cell Biol. 4, 509-513.
184. Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M., Swofford, R., Venkatesan, S., Farber, J. M., and Fauci, A. S. (1997). Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389, 981-985.
185. Wenzel-Seifert, K., and Seifert, R. (2003). Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor. Biochem. Biophys. Res. Commun. 301, 693-698.
186. Wenzel-Seifert, K., and Seifert, R. (2003). Functional differences between human formyl peptide receptor isoforms 26, 98, and G6. Naunyn Schmiedebergs Arch. Pharmacol. 367, 509-515.
187. Weisel, R. A. (1995). Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7, 48-53.
188. Whistler, J. L., Gerber, B. O., Meng, E. C., Baranski, T. J., von Zastrow, M., and Bourne, H. R. (2002). Constitutive activation and endocytosis of the complement factor 5a receptor: Evidence for multiple activated conformations of a G protein-coupled receptor. Traffic 3, 866-877.
189. Wilde, M. W., Carlson, K. E., Manning, D. R., and Zigmond, S. H. (1989). Chemoattractant-stimulated GTPase activity is decreased on membranes from polymorphonuclear leukocytes incubated in chemoattractant. J. Biol. Chem. 264, 190-196.
190. Wilkinson, P. C., Komai-Koma, M., and Newman, I. (1997). Locomotion and chemotaxis of lymphocytes. Autoimmunity 26, 55-72.
191. Wu, D., LaRosa, G. J., and Simon, M. I. (1993). G protein-coupled signal transduction pathways for interleukin-8. Science 261, 101-103.
192. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C., and Sodroski, J. (1996a). CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183.
193. Wu, L., Ruffing, N., Shi, X., Newman, W., Soler, D., Mackay, C. R., and Qin, S. (1996b). Discrete steps in binding and signaling of interleukin-8 with its receptor. J. Biol. Chem. 271, 31202-31209.
194. Xie, W., Jiang, H., Wu, Y., and Wu, D. (1997). Two basic amino acids in the second inner loop of the interleukin-8 receptor are essential for Galpha16 coupling. J. Biol. Chem. 272, 24948-24951.
195. Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., and Leonard, E. J. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84, 9233-9237.
196. Zhang, X., Boyar, W., Toth, M. J., Wennogle, L., and Gonnella, N. C. (1997). Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy. Proteins 28, 261-267.
197. Zlotnik, A., and Yoshie, O. (2000). Chemokines: A new classification system and their role in immunity. Immunity 12, 121-127.
198. Zuiderweg, E. R., Nettesheim, D. G., Mollison, K. W., and Carter, G. W. (1989). Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. Biochem. 28, 172-185.